These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease. Catania M; Di Fede G Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234 [TBL] [Abstract][Full Text] [Related]
3. The Prion-like Properties of Amyloid-beta Peptide and Tau: Is there Any Risk of Transmitting Alzheimer's Disease During Neurosurgical Interventions? Padilla-Zambrano HS; García-Ballestas E; Quiñones-Ossa GA; Sibaja-Perez AE; Agrawal A; Moscote-Salazar LR; Menéndez-González M Curr Alzheimer Res; 2020; 17(9):781-789. PubMed ID: 33280597 [TBL] [Abstract][Full Text] [Related]
5. Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target. Holmes BB; Diamond MI J Biol Chem; 2014 Jul; 289(29):19855-61. PubMed ID: 24860099 [TBL] [Abstract][Full Text] [Related]
6. [The role of proteins in neurodegenerative disease]. Szwed A; Miłowska K Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103 [TBL] [Abstract][Full Text] [Related]
7. Prion-like Mechanisms in Alzheimer's Disease. Yin RH; Tan L; Jiang T; Yu JT Curr Alzheimer Res; 2014; 11(8):755-64. PubMed ID: 25212914 [TBL] [Abstract][Full Text] [Related]
8. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. Bloom GS JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463 [TBL] [Abstract][Full Text] [Related]
9. Impact of the cellular prion protein on amyloid-β and 3PO-tau processing. Schmitz M; Wulf K; Signore SC; Schulz-Schaeffer WJ; Kermer P; Bähr M; Wouters FS; Zafar S; Zerr I J Alzheimers Dis; 2014; 38(3):551-65. PubMed ID: 24028865 [TBL] [Abstract][Full Text] [Related]
10. Tauons and prions: infamous cousins? Novak P; Prcina M; Kontsekova E J Alzheimers Dis; 2011; 26(3):413-30. PubMed ID: 21694453 [TBL] [Abstract][Full Text] [Related]
11. Untangling amyloid-β, tau, and metals in Alzheimer's disease. Savelieff MG; Lee S; Liu Y; Lim MH ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614 [TBL] [Abstract][Full Text] [Related]
13. Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease. Cohen M; Appleby B; Safar JG Prion; 2016; 10(1):9-17. PubMed ID: 26809345 [TBL] [Abstract][Full Text] [Related]
14. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis. Lee M; McGeer E; McGeer PL Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677 [TBL] [Abstract][Full Text] [Related]
15. Prion-like features of misfolded Aβ and tau aggregates. Morales R; Callegari K; Soto C Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736 [TBL] [Abstract][Full Text] [Related]
16. Understanding the cause of sporadic Alzheimer's disease. Zetterberg H; Mattsson N Expert Rev Neurother; 2014 Jun; 14(6):621-30. PubMed ID: 24852227 [TBL] [Abstract][Full Text] [Related]
17. Yeast Model of Amyloid-β and Tau Aggregation in Alzheimer's Disease. Moosavi B; Mousavi B; Macreadie IG J Alzheimers Dis; 2015; 47(1):9-16. PubMed ID: 26402750 [TBL] [Abstract][Full Text] [Related]
18. The red-hot debate about transmissible Alzheimer's. Abbott A Nature; 2016 Mar; 531(7594):294-7. PubMed ID: 26983522 [No Abstract] [Full Text] [Related]